Skip to main content

Table 3 Predictors for mortality

From: Endoscopic variceal obturation and retrograde transvenous obliteration for acute gastric cardiofundal variceal bleeding in liver cirrhosis

Variables

Rating

Univariate analysis

Hazard ratio

95% CI

P value

Age

Years

1.005

0.979–1.031

0.721

Sex

0 = women; 1 = men

1.418

0.702–2.865

0.330

Diabetes

0 = no; 1 = yes

1.039

0.559–1.932

0.904

Etiology

0 = other; 1 = alcohol

1.750

0.959–3.195

0.068

Hemoglobin

g/dL

1.003

0.896–1.124

0.955

Platelet count

× 109/L

0.998

0.992–1.005

0.613

INR

 

1.268

0.860–1.871

0.231

Alanine aminotransferase

IU/L

1.001

0.995–1.007

0.748

Total bilirubin

mg/dL

1.050

0.992–1.110

0.090

Serum albumin

g/dL

0.674

0.363–1.252

0.212

MELD score

 

1.089

1.030–1.151

0.002

Type of varices

0 = GOV2; 1 = IGV1

1.696

0.932–3.085

0.084

Type of treatment

0 = RTO; 1 = EVO

1.174

0.648–2.127

0.598

Beta-blocker

0 = no; 1 = yes

1.381

0.741–2.574

0.309

Post EVL

0 = no; 1 = yes

1.570

0.859–2.866

0.142

  1. IGV1 isolated gastric varices type 1, GOV2 gastroesophageal varices type 2, INR international normalized ratio, MELD model for end-stage liver disease, EVO endoscopic variceal obturation, RTO retrograde transvenous obliteration, EVL endoscopic variceal ligation